MDxHealth Accounts Payable vs Short Long Term Debt Total Analysis

MDXH Stock  USD 2.00  0.04  2.04%   
MDxHealth financial indicator trend analysis is infinitely more than just investigating MDxHealth SA ADR recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MDxHealth SA ADR is a good investment. Please check the relationship between MDxHealth Accounts Payable and its Short Long Term Debt Total accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MDxHealth SA ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Accounts Payable vs Short Long Term Debt Total

Accounts Payable vs Short Long Term Debt Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MDxHealth SA ADR Accounts Payable account and Short Long Term Debt Total. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between MDxHealth's Accounts Payable and Short Long Term Debt Total is 0.55. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Short Long Term Debt Total in the same time period over historical financial statements of MDxHealth SA ADR, assuming nothing else is changed. The correlation between historical values of MDxHealth's Accounts Payable and Short Long Term Debt Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of MDxHealth SA ADR are associated (or correlated) with its Short Long Term Debt Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Long Term Debt Total has no effect on the direction of Accounts Payable i.e., MDxHealth's Accounts Payable and Short Long Term Debt Total go up and down completely randomly.

Correlation Coefficient

0.55
Relationship DirectionPositive 
Relationship StrengthWeak

Accounts Payable

An accounting item on the balance sheet that represents MDxHealth obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of MDxHealth SA ADR are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Short Long Term Debt Total

Most indicators from MDxHealth's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MDxHealth SA ADR current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MDxHealth SA ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
As of now, MDxHealth's Selling General Administrative is increasing as compared to previous years. The MDxHealth's current Tax Provision is estimated to increase to about 134.4 K, while Issuance Of Capital Stock is projected to decrease to under 39.3 M.
 2021 2022 2023 2024 (projected)
Interest Expense1.9M6.1M5.6M5.9M
Depreciation And Amortization3.0M4.9M6.9M7.2M

MDxHealth fundamental ratios Correlations

0.860.790.76-0.050.930.52-0.870.360.93-0.40.360.920.89-0.110.830.920.50.210.940.910.74-0.570.450.750.87
0.860.950.63-0.510.970.78-0.920.120.93-0.430.120.950.970.130.740.980.130.40.890.950.55-0.780.020.640.93
0.790.950.5-0.580.940.76-0.830.090.88-0.250.090.940.940.190.60.940.050.410.810.910.43-0.82-0.080.530.92
0.760.630.50.180.690.23-0.820.470.61-0.480.470.650.55-0.290.860.620.640.490.650.720.81-0.190.470.950.49
-0.05-0.51-0.580.18-0.35-0.810.240.59-0.370.120.59-0.34-0.5-0.510.07-0.440.75-0.11-0.28-0.280.170.690.620.1-0.49
0.930.970.940.69-0.350.69-0.930.230.94-0.340.230.990.960.070.80.980.290.390.910.980.63-0.720.180.720.92
0.520.780.760.23-0.810.69-0.55-0.530.78-0.41-0.530.650.820.380.330.79-0.46-0.020.750.570.34-0.79-0.080.330.82
-0.87-0.92-0.83-0.820.24-0.93-0.55-0.37-0.820.38-0.37-0.92-0.840.09-0.93-0.88-0.42-0.53-0.81-0.96-0.630.52-0.19-0.84-0.77
0.360.120.090.470.590.23-0.53-0.370.020.091.00.270.03-0.430.490.090.90.560.030.380.20.190.160.34-0.03
0.930.930.880.61-0.370.940.78-0.820.02-0.450.020.920.980.090.690.980.150.10.990.870.65-0.760.280.630.98
-0.4-0.43-0.25-0.480.12-0.34-0.410.380.09-0.450.09-0.21-0.4-0.05-0.32-0.41-0.02-0.13-0.48-0.29-0.570.31-0.12-0.39-0.37
0.360.120.090.470.590.23-0.53-0.371.00.020.090.270.03-0.430.490.090.90.560.030.380.20.190.160.34-0.03
0.920.950.940.65-0.340.990.65-0.920.270.92-0.210.270.940.020.80.960.310.360.880.980.55-0.690.170.680.91
0.890.970.940.55-0.50.960.82-0.840.030.98-0.40.030.940.150.661.00.080.20.950.90.55-0.830.110.570.99
-0.110.130.19-0.29-0.510.070.380.09-0.430.09-0.05-0.430.020.15-0.330.11-0.50.040.020.020.02-0.56-0.42-0.260.17
0.830.740.60.860.070.80.33-0.930.490.69-0.320.490.80.66-0.330.720.620.430.720.840.64-0.220.450.890.59
0.920.980.940.62-0.440.980.79-0.880.090.98-0.410.090.961.00.110.720.150.230.960.930.6-0.790.160.640.98
0.50.130.050.640.750.29-0.46-0.420.90.15-0.020.90.310.08-0.50.620.150.340.210.40.480.250.560.560.04
0.210.40.410.49-0.110.39-0.02-0.530.560.1-0.130.560.360.20.040.430.230.340.040.490.14-0.12-0.360.430.09
0.940.890.810.65-0.280.910.75-0.810.030.99-0.480.030.880.950.020.720.960.210.040.840.7-0.680.40.670.95
0.910.950.910.72-0.280.980.57-0.960.380.87-0.290.380.980.90.020.840.930.40.490.840.6-0.660.140.730.86
0.740.550.430.810.170.630.34-0.630.20.65-0.570.20.550.550.020.640.60.480.140.70.6-0.40.580.790.54
-0.57-0.78-0.82-0.190.69-0.72-0.790.520.19-0.760.310.19-0.69-0.83-0.56-0.22-0.790.25-0.12-0.68-0.66-0.40.26-0.19-0.84
0.450.02-0.080.470.620.18-0.08-0.190.160.28-0.120.160.170.11-0.420.450.160.56-0.360.40.140.580.260.520.14
0.750.640.530.950.10.720.33-0.840.340.63-0.390.340.680.57-0.260.890.640.560.430.670.730.79-0.190.520.51
0.870.930.920.49-0.490.920.82-0.77-0.030.98-0.37-0.030.910.990.170.590.980.040.090.950.860.54-0.840.140.51
Click cells to compare fundamentals

MDxHealth Account Relationship Matchups

MDxHealth fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets40.6M31.9M75.1M119.1M129.1M135.6M
Short Long Term Debt Total11.0M15.9M15.6M39.8M41.3M43.3M
Other Current Liab909K4.1M3.7M6.3M8.6M9.0M
Total Current Liabilities10.4M13.0M16.4M18.3M19.5M10.0M
Total Stockholder Equity19.7M5.8M46.9M9.3M7.2M6.8M
Property Plant And Equipment Net2.5M3.7M5.0M7.9M9.9M10.4M
Net Debt(11.0M)(82K)(42.9M)24.3M18.9M19.8M
Retained Earnings(186.6M)(215.3M)(244.3M)(288.3M)(331.4M)(314.9M)
Cash22.1M16.0M58.5M15.5M22.4M27.4M
Non Current Assets Total9.7M8.8M8.5M90.0M91.0M95.5M
Cash And Short Term Investments22.1M16.0M58.5M15.5M22.4M27.4M
Common Stock Shares Outstanding6.3M8.3M12.2M15.9M25.9M27.2M
Liabilities And Stockholders Equity40.6M31.9M75.1M119.1M129.1M135.6M
Non Current Liabilities Total10.5M13.0M11.7M91.5M102.4M107.5M
Other Stockholder Equity141.8M144.4M136.3M153.2M176.2M185.0M
Total Liab20.9M26.0M28.2M109.8M121.9M128.0M
Total Current Assets30.9M23.1M66.6M29.1M38.2M37.6M
Short Term Debt1.2M3.6M5.3M1.8M2.1M1.2M
Intangible Assets7.3M5.1M3.4M46.2M44.3M46.6M
Common Stock62.8M76.7M128.5M133.5M173.9M182.6M
Accounts Payable5.0M5.3M7.5M10.2M8.8M6.5M
Current Deferred Revenue3.3M3.2M2.7M472K424.8K403.6K
Net Receivables6.7M3.9M4.8M9.4M11.3M10.8M
Inventory1.2M2.3M1.9M2.3M2.8M1.7M
Accumulated Other Comprehensive Income(918K)(1.3M)(1.0M)(444K)11.5M12.1M
Net Tangible Assets12.5M791K43.5M(72.8M)(65.5M)(62.2M)
Net Invested Capital29.3M18.9M59.0M44.8M43.4M45.8M
Net Working Capital20.5M10.1M50.2M10.9M18.6M19.8M
Property Plant Equipment2.5M3.7M5.0M7.9M9.1M9.5M
Long Term Debt9.1M10.3M7.7M34.9M35.6M17.9M
Capital Lease Obligations1.4M2.8M3.5M4.3M5.1M3.2M
Short Long Term Debt565K2.8M4.4M616K643K610.9K
Capital Stock62.8M76.7M128.5M133.5M173.9M115.4M

Currently Active Assets on Macroaxis

When determining whether MDxHealth SA ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MDxHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mdxhealth Sa Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mdxhealth Sa Adr Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MDxHealth SA ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MDxHealth. If investors know MDxHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MDxHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.53)
Revenue Per Share
3.099
Quarterly Revenue Growth
0.205
Return On Assets
(0.11)
Return On Equity
(2.41)
The market value of MDxHealth SA ADR is measured differently than its book value, which is the value of MDxHealth that is recorded on the company's balance sheet. Investors also form their own opinion of MDxHealth's value that differs from its market value or its book value, called intrinsic value, which is MDxHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MDxHealth's market value can be influenced by many factors that don't directly affect MDxHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MDxHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if MDxHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MDxHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.